期刊文献+

CD59基因的突变并真核表达载体的构建 被引量:2

SITE-DIRECTED MUTAGENESIS OF CD59 GENE AND CONSTRUCTION OF EUKARYOTIC EXPRESSION SYSTEM
下载PDF
导出
摘要 目的构建两种活性位点相关性CD59突变基因,并重组入真核表达载体。方法选取物种间高度保守W40位点及相邻位置为突变位点,重叠延伸PCR(Overlap extension PCR)法构建两种CD59基因点突变,一种是编码W40的密码子TGG缺失突变,另一种是C39W40K41→W39W40W41的相应基因突变,各设计两条常规引物和两条反向互补突变引物,以已构建CD59 cDNA为模板,三重PCR定点诱变扩增突变基因,重组入克隆载体PMD18-T-Vector,EcoRⅠ单酶切获得目的基因,重组入真核表达载体pIRES。结果通过PCR定点诱变成功获得两种目的CD59突变基因,序列测定及酶切鉴定结果均证实成功构建了pIRES-m1CD59、pIRES-m2CD59重组真核表达载体系统,突变CD59基因长度约500 bp。结论重叠延伸PCR法诱变经济可靠,重组质粒的构建为进一步研究CD59的抗补体活性奠定了基础。 Objective To construct two CD59 active site relative mutagenesis and clone mutants into eukaryotic expression system. Methods The highly conserved W40 and its vicinity were selected for mutant, and site-directed mutagenesis with deleting residue W40 site and changing C39W40K41→W39W40W41 were performed by Overlap extention PCR. Two normal primers and two mutagenesis reverse complemented primers were designed, cDNAs as templates,tri-PCR were used to amplify the mutant genes. Mutant CD59 DNAs were subcloned into the cloning vector PMD18-T-Vector, then cloned into the eukaryotic expression vector pIRES after digested by EcoR Ⅰ . Results Mutants were successfully constructed and confirmed by sequence analysis. Recombinant plasmids of pIRES-mlCD59 and pIRES-m2 CD59 were successfully constructed according to sequence and enzyme digestion analysis. The mutant gene was about 500 bp. Conclusion Overlap extension PCR is economical and in reliable, and the recombinants will be applied for luther study on CD59 anticornplernent activity.
出处 《青岛大学医学院学报》 CAS 2008年第2期95-98,共4页 Acta Academiae Medicinae Qingdao Universitatis
基金 国家自然科学基金资助项目(30170893)
关键词 抗原 CD59 点突变 真核表达 Antigens, CD59 Point mutation Overlap extension PCR Eukaryotic expression
  • 相关文献

参考文献7

  • 1NINOMIYA H, STEWART B H, ROLLINS S A, et al. Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity[J]. J Biol Chem, 1992,267 : 8404. 被引量:1
  • 2FARKAS I, BARANYI L, LSHIKAWA Y, et al. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as CSb-9[J]. J Physiol, 2002,39(2) :537. 被引量:1
  • 3YU J, ABAGYAN R, DONG S, et al. Mapping the active Site of CD59[J]. J Exp Med, 1997,185(4) ,745. 被引量:1
  • 4BJORGE L, STOIBER H, DIERICH M P, et al. Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy[J]. Scand J Immuno, 2006,63 (5) :355. 被引量:1
  • 5HUANG Y, QIAO F, ABAGYAN R, et al. Defining the CD59-C9 Binding Interaction[J]. J Biol Chem, 2006, 281 (37) : 27398. 被引量:1
  • 6罗师平,冷希岗.基于PCR的体外诱变技术[J].国外医学(生物医学工程分册),2005,28(3):188-192. 被引量:25
  • 7徐芳,姚泉洪,熊爱生,彭日荷,侯喜林,曹兵.重叠延伸PCR技术及其在基因工程上的应用[J].分子植物育种,2006,4(5):747-750. 被引量:45

二级参考文献25

共引文献68

同被引文献18

  • 1程颖,高美华,王冰,王秋波.通过噬菌体筛选表达人CD59的CHO细胞结合的内化短肽[J].齐鲁医学杂志,2006,21(3):204-206. 被引量:2
  • 2秦诚,蔡小勇.补体调节蛋白CD46、CD55及CD59在肿瘤免疫治疗中的研究进展[J].癌症,2006,25(11):1450-1453. 被引量:19
  • 3吴宁,高美华.人突变CD59基因在CHO细胞的表达、检测及生物活性研究[J].中国免疫学杂志,2007,23(5):456-459. 被引量:3
  • 4DONIN, JURIANZ K, ZIPOREN L, et al. Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid[J]. Clin Exp Immunol, 2003,131(2) :254-263. 被引量:1
  • 5FISHELSON Z, DONIN N, ZELL S, et al. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors [J]. Mol Immunol, 2003,40(2-4) : 109-123. 被引量:1
  • 6FONSATTI E, DI GIACOMO A M, MAIO M. Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy[J]? J Transl Med, 2004,2(1):21-25. 被引量:1
  • 7RAVINDRANATH N M, NISHIMOTO K, CHU K, et al. Cell-surface expression of complement restriction factors and sialyl Lewis antigens in oral carcinoma: relevance to chemoimmunotherapy[J]. Anicancer Res, 2000,20 (1A) : 21-26. 被引量:1
  • 8FROMOROMOWITZ F B, VIOLA M V, CHAO S, et al. Ras p21 expression in the progression of breast cancer[J]. Hum Pathol, 1987,18(12) :1268-1275. 被引量:1
  • 9HUGHES J, NANGAKU M, ALPERS C E, et al. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis[J]. Am J Physiol Renal Physiol, 2000, 278(5) : F747-757. 被引量:1
  • 10KAWANO M, TSUNODA S, KONI I, et al. Decreased expression of 20 kD homologous restriction factor (HRF20, CD59) on Tlymphocytes in Epstein Barr virus (EBV)-induced infectious mononucleosis[J]. Clin Eacp Immunol, 1997, 108 (2):260-265. 被引量:1

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部